| Gustave Roussy | |
| Location: | Villejuif |
| Country: | France |
| Type: | Research center, Teaching Hospital |
| Speciality: | Specialist hospital |
| Emergency: | Yes |
| Beds: | 457 |
| Founded: | 1926 |
| Website: | https://www.gustaveroussy.fr/en |
Gustave Roussy is a cancer-research hospital in Europe. It is located in the Parisian area. It is named after Gustave Roussy, a Swiss-French neuropathologist.
In April 2019, three new interventional radiology rooms were inaugurated, making it the largest platform of this type in Europe, entirely dedicated to oncology. Interventional radiology is a so-called "minimally invasive" diagnostic and treatment technique, which uses images to guide access to deep-lying organs, without having to "open up" patients. Gustave Roussy carries out more than 4,000 operations of this type each year.[1]
Together with the Faculty of Medicine of the University of Paris-Saclay, the Gustave-Roussy Institute runs the School of Cancer Sciences, a university establishment specializing in oncology. The lessons take place at the Cancer Campus in Villejuif in the Val-de-Marne.
In the various courses offered by the faculty of medicine (adult, adolescent and child oncology; surgery; best practices; medical imaging; radiotherapy; other courses), the establishment integrates the Doctoral School of Oncology, Biology, Medicine, Health (and its Master 2 in Biology and Health, Cancerology specialty) created with the École Normale Supérieure Paris-Saclay.[3]
Directed in 2015 by Pierre Blanchard, the school had trained nearly 2,800 students and awarded twenty-six university degrees.
In 2020, the Institut Gustave Roussy was ranked as the first leading cancer hospital in Europe and in the top 5 best specialized hospitals in the world.[4]
In 2017, a virologist from the Institut Gustave Roussy was sentenced to 5 years in prison for poisoning colleagues with sodium azide in 2014.[5]